{
 "url": "https://etfiq.com/funds/bib/holdings/",
 "section": "funds",
 "title": "BIB Holdings: 239 Positions (Oct 22, 2026) | ETFIQ",
 "description": "BIB holdings as of Oct 22, 2026: swaps on Nasdaq Biotechnology Index and Nasdaq Bio Index worth 137.3% of net assets, and the cash behind them.",
 "as_of": "Oct 22, 2026",
 "ticker": "BIB",
 "fund": "ProShares Ultra Nasdaq Biotechnology",
 "fund_page": "https://etfiq.com/funds/bib",
 "positions": 239,
 "positions_listed_on_page": 100,
 "lead": "BIB held swaps on Nasdaq Biotechnology Index and Nasdaq Bio Index worth 137.3% of its net assets on Oct 22, 2026. With the 62.4% it holds directly, its exposure is 199.7%.",
 "source": {
  "name": "ProShares",
  "url": "https://www.proshares.com/our-etfs/leveraged-and-inverse/bib",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-22",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA",
   "ticker": "Nasdaq Biotechnology Index",
   "weight_pct": 36.14,
   "page": null
  },
  {
   "rank": 2,
   "holding": "NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA",
   "ticker": "Nasdaq Biotechnology Index",
   "weight_pct": 30.2,
   "page": null
  },
  {
   "rank": 3,
   "holding": "NASDAQ BIO INDEX SWAP BNP PARIBAS",
   "ticker": "Nasdaq Bio Index",
   "weight_pct": 28.87,
   "page": null
  },
  {
   "rank": 4,
   "holding": "NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL",
   "ticker": "Nasdaq Biotechnology Index",
   "weight_pct": 19.22,
   "page": null
  },
  {
   "rank": 5,
   "holding": "NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE",
   "ticker": "Nasdaq Biotechnology Index",
   "weight_pct": 18.31,
   "page": null
  },
  {
   "rank": 6,
   "holding": "Gilead Sciences Inc",
   "ticker": null,
   "weight_pct": 5.4,
   "page": null
  },
  {
   "rank": 7,
   "holding": "Amgen Inc",
   "ticker": null,
   "weight_pct": 5.23,
   "page": null
  },
  {
   "rank": 8,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": null,
   "weight_pct": 4.94,
   "page": null
  },
  {
   "rank": 9,
   "holding": "NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG",
   "ticker": "Nasdaq Biotechnology Index",
   "weight_pct": 4.58,
   "page": null
  },
  {
   "rank": 10,
   "holding": "Regeneron Pharmaceuticals",
   "ticker": null,
   "weight_pct": 3.41,
   "page": null
  },
  {
   "rank": 11,
   "holding": "Moderna Inc",
   "ticker": null,
   "weight_pct": 3.33,
   "page": null
  },
  {
   "rank": 12,
   "holding": "Illumina Inc",
   "ticker": null,
   "weight_pct": 1.67,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Revolution Medicines Inc",
   "ticker": null,
   "weight_pct": 1.65,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Biogen Inc",
   "ticker": null,
   "weight_pct": 1.54,
   "page": null
  },
  {
   "rank": 15,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": null,
   "weight_pct": 1.25,
   "page": null
  },
  {
   "rank": 16,
   "holding": "Royalty Pharma PLC- Cl A",
   "ticker": null,
   "weight_pct": 1.17,
   "page": null
  },
  {
   "rank": 17,
   "holding": "Roivant Sciences Ltd",
   "ticker": null,
   "weight_pct": 1.11,
   "page": null
  },
  {
   "rank": 18,
   "holding": "United Therapeutics Corp",
   "ticker": null,
   "weight_pct": 1.03,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Argenx SE - ADR",
   "ticker": null,
   "weight_pct": 0.98,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Incyte Corp",
   "ticker": null,
   "weight_pct": 0.98,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Guardant Health Inc",
   "ticker": null,
   "weight_pct": 0.9,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Viatris Inc",
   "ticker": null,
   "weight_pct": 0.87,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Insmed Inc",
   "ticker": null,
   "weight_pct": 0.85,
   "page": null
  },
  {
   "rank": 24,
   "holding": "Medpace Holdings Inc",
   "ticker": null,
   "weight_pct": 0.75,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Exelixis Inc",
   "ticker": null,
   "weight_pct": 0.67,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 37.63
  }
 ],
 "weights": "share of net assets, as the source states them; a swap line’s weight is the exposure it gives",
 "csv": "https://etfiq.com/funds/bib/holdings/bib-holdings.csv",
 "json_book": "https://etfiq.com/funds/bib/holdings/index.json",
 "markdown": "https://etfiq.com/funds/bib/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of BIB, data as of Oct 22, 2026. https://etfiq.com/funds/bib/holdings/",
 "exposure_pct": {
  "swaps": 137.3,
  "futures": 0,
  "held_directly": 62.4,
  "together": 199.7,
  "daily_target": 2.0,
  "swaps_track": [
   "Nasdaq Biotechnology Index",
   "Nasdaq Bio Index"
  ]
 }
}